250 related articles for article (PubMed ID: 25303376)
1. Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease.
Cesarini M; Danese S
Aliment Pharmacol Ther; 2014 Nov; 40(10):1243. PubMed ID: 25303376
[No Abstract] [Full Text] [Related]
2. Therapeutic drug monitoring, mucosal healing, deep remission: the path to nirvana in Crohn's disease?
Moss AC
Clin Gastroenterol Hepatol; 2014 Mar; 12(3):432-3. PubMed ID: 24370555
[No Abstract] [Full Text] [Related]
3. Meningococcal meningoencephalitis after certolizumab pegol treatment in a patient with Crohn's disease.
Majumder S; Kumar A
J Crohns Colitis; 2013 Feb; 7(1):e19. PubMed ID: 22742971
[No Abstract] [Full Text] [Related]
4. Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study.
Sandborn WJ; Lee SD; Randall C; Gutierrez A; Schwartz DA; Ambarkhane S; Kayhan C; Pierre-Louis B; Schreiber S; Lichtenstein GR
Aliment Pharmacol Ther; 2014 Oct; 40(8):903-16. PubMed ID: 25146586
[TBL] [Abstract][Full Text] [Related]
5. [Certolizumab pegol--new possibilities in the treatment of Crohn's disease].
Lazebnik LB; Kniazev OV
Eksp Klin Gastroenterol; 2012; (3):100-5. PubMed ID: 22830233
[No Abstract] [Full Text] [Related]
6. Certolizumab pegol: new drug. As a last resort in Crohn's disease: continue to use other TNF alpha inhibitors.
Prescrire Int; 2009 Jun; 18(101):108-10. PubMed ID: 19637418
[TBL] [Abstract][Full Text] [Related]
7. Maintenance therapy with certolizumab pegol for Crohn's disease.
Schreiber S; Khaliq-Kareemi M; Lawrance IC; Thomsen OØ; Hanauer SB; McColm J; Bloomfield R; Sandborn WJ;
N Engl J Med; 2007 Jul; 357(3):239-50. PubMed ID: 17634459
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pharmacokinetics and pharmacodynamics and clinical efficacy of certolizumab pegol for Crohn's disease.
Tun GS; Lobo AJ
Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):317-27. PubMed ID: 25586216
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of fistulizing Crohn's disease with certolizumab pegol.
Danese S; Stefanelli T; Omodei P; Zatelli S; Bonifacio C; Balzarini L; Repici A; Malesci A
Inflamm Bowel Dis; 2008 Feb; 14(2):292-3. PubMed ID: 17932987
[No Abstract] [Full Text] [Related]
10. [Compassionate use of certolizumab in Crohn's disease].
Planas-Giner A; Salort-Llorca C; Garriga-Biosca R; Esteve-Comas M
Farm Hosp; 2008; 32(2):127-9. PubMed ID: 18783714
[No Abstract] [Full Text] [Related]
11. Efficacy and safety of certolizumab pegol for Crohn's disease: a systematic review and meta-analysis.
Da W; Zhu J; Wang L; Lu Y
Adv Ther; 2013 May; 30(5):541-53. PubMed ID: 23681504
[TBL] [Abstract][Full Text] [Related]
12. Certolizumab pegol in Crohn's disease.
Patel VK; Ghosh S
Drugs Today (Barc); 2008 Nov; 44(11):837-44. PubMed ID: 19180261
[TBL] [Abstract][Full Text] [Related]
13. Certolizumab pegol for the treatment of Crohn's disease.
Sandborn WJ; Feagan BG; Stoinov S; Honiball PJ; Rutgeerts P; Mason D; Bloomfield R; Schreiber S;
N Engl J Med; 2007 Jul; 357(3):228-38. PubMed ID: 17634458
[TBL] [Abstract][Full Text] [Related]
14. Certolizumab pegol in the treatment of Crohn's disease.
Ferrante M; Vermeire S; Rutgeerts P
Expert Opin Biol Ther; 2013 Apr; 13(4):595-605. PubMed ID: 23451881
[TBL] [Abstract][Full Text] [Related]
15. Certolizumab pegol: a TNF-{alpha} antagonist for the treatment of moderate-to-severe Crohn's disease.
Smith LS; Nelson M; Dolder CR
Ann Pharmacother; 2010 Feb; 44(2):333-42. PubMed ID: 20118143
[TBL] [Abstract][Full Text] [Related]
16. A review and expert opinion of the use of certolizumab for Crohn's disease.
Evans AT; Lee SD
Expert Opin Biol Ther; 2012 Mar; 12(3):363-70. PubMed ID: 22339409
[TBL] [Abstract][Full Text] [Related]
17. Anti-TNF antibodies for Crohn's disease.
Camilleri M
N Engl J Med; 2007 Oct; 357(16):1662; author reply 1662. PubMed ID: 17942882
[No Abstract] [Full Text] [Related]
18. Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease.
Mocciaro F; Orlando A; Renna S; Rizzuto MR; Cottone M
J Crohns Colitis; 2011 Apr; 5(2):173-4. PubMed ID: 21453892
[No Abstract] [Full Text] [Related]
19. Anti-TNF antibodies for Crohn's disease--in pursuit of the perfect clinical trial.
Lewis JD
N Engl J Med; 2007 Jul; 357(3):296-8. PubMed ID: 17634466
[No Abstract] [Full Text] [Related]
20. Certolizumab pegol for the management of Crohn's disease in adults.
Rivkin A
Clin Ther; 2009 Jun; 31(6):1158-76. PubMed ID: 19695385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
